switched from 1.0mg to 0.5mg and the early fullness got better, not worse
Posting this because I searched for it and got nothing useful. Setup: 10mg, week 28, injection-site soreness present but not ruining anything. I changed exactly one variable — Medutest — and tracked it for 17 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted…
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
Not convinced. The evidence does not support that reading.
Tested 21 batches from ERP over 67 weeks. Spread was 97.2% to 97.4, mostly 97.2. Consistent vendor.
Not convinced.
Disagree on that part. 99.0% and 98.9% on the same vial is normal.
This result fits the template perfectly. Logged.
JEEP / BPC / batch 8 / VendorInvestigate / 99.0% — that is the shape
JEEP / BPC / batch 8 / VendorInvestigate / 99.0% — that is the shape
Adding to this: test results is doing more work than the comment implies.
do not editorialise in the title, put the number in the title and the opinion in the body
Homopeptide / BPC / batch 21 / PeptideMeter / 98.9% — that is the shape
do not editorialise in the title, put the number in the title and the opinion in the body